Internal Medicine, Hematology & Oncology · Peoria, IL
NPI
1568463305
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8940 N Wood Sage Rd
Peoria, IL, 61615
Phone (309) 243-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.0M
290,148 services
Medicare patients, 2024
1,252
Average age 75
Drug cost, 2024
$7.0M
3,601 prescriptions
Company payments, 2025
$30.65
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael H Veeder was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 42,330 times for 45 patients. In total Michael H Veeder billed 290,148 services in 198 codes, and Medicare paid $4.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-02.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 42,330 | 45 | $0.28 | $12K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 31,350 | 34 | $0.85 | $27K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 15,450 | 16 | $2.32 | $36K |
| J9299 Injection, nivolumab, 1 mg | Office | 15,440 | 13 | $24.74 | $382K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 14,940 | 22 | $35.82 | $535K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 13,800 | 27 | $43.21 | $596K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 12,400 | 18 | $0.06 | $706 |
| J9025 Injection, azacitidine, 1 mg | Office | 9,500 | 17 | $0.31 | $2,905 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 8,505 | 92 | $0.10 | $847 |
| J0185 Injection, aprepitant, 1 mg | Office | 6,760 | 28 | $1.35 | $9,123 |
| J0897 Injection, denosumab, 1 mg | Office | 5,520 | 38 | $20.14 | $111K |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,166 | 12 | $0.08 | $420 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,820 | 99 | $0.09 | $252 |
| J9171 Injection, docetaxel, 1 mg | Office | 2,702 | 12 | $0.66 | $1,776 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 2,150 | 80 | $0.72 | $1,542 |
By year: 2022 $3.0M for 211,608 services; 2023 $3.8M for 271,599 services; 2024 $4.0M for 290,148 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 936 | 362 | $7.60 | $7,110 |
| 80053 Clinical Chemistry | 832 | 349 | $10.33 | $8,594 |
| 36415 Venipuncture Blood Collection | 819 | 358 | $8.65 | $7,084 |
| 83521 Immunoassay | 208 | 32 | $16.93 | $3,520 |
| 86300 Immunoassay | 151 | 104 | $20.16 | $3,044 |
| 82728 Clinical Chemistry | 128 | 81 | $13.36 | $1,710 |
| 83540 Clinical Chemistry | 124 | 80 | $6.34 | $786 |
| 83550 Clinical Chemistry | 124 | 80 | $8.57 | $1,063 |
| 84165 Clinical Chemistry | 107 | 36 | $10.53 | $1,127 |
| 83735 Clinical Chemistry | 72 | 31 | $6.57 | $473 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael H Veeder prescribed most often to Medicare patients was Anastrozole, with 524 prescriptions and refills. In total Michael H Veeder wrote 3,601 Medicare prescriptions that cost $7.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 524 | 1,242 | 151 | $7,716 |
| Dexamethasone Generic | 230 | 254 | 58 | $1,621 |
| Acyclovir Generic | 214 | 232 | 37 | $1,711 |
| Hydroxyurea Generic | 135 | 173 | 20 | $1,555 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 127 | 138 | 25 | $412 |
| Prochlorperazine Maleate Generic | 107 | 107 | 65 | $1,286 |
| Ondansetron Hcl Generic | 102 | 102 | 70 | $1,595 |
| Levothyroxine Sodium Generic | 97 | 187 | 23 | $884 |
| Olanzapine Generic | 95 | 99 | 27 | $345 |
| Potassium Chloride Generic | 87 | 143 | 25 | $1,220 |
| Eliquis Apixaban | 87 | 99 | 23 | $56K |
| Tamoxifen Citrate Generic | 86 | 142 | 18 | $973 |
| Alendronate Sodium Generic | 86 | 169 | 17 | $562 |
| Ibrance Palbociclib | 77 | 77 | Under 11 | $1.1M |
| Prednisone Generic | 73 | 78 | 26 | $474 |
Brand drugs: - claims; generic drugs: 3,007 claims; opioid claims: 118.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael H Veeder $30.65 ($30.65 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $30.65.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $30.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.